Viatris Inc. Secures FDA Nod for Generic Symbicort Equivalent, Breyna
US-based Viatris Inc., (NASDAQ: VTRS) has announced that the US Food and Drug Administration (FDA)...
Generic drugs
Novartis Q2 2023 Results Exceed Expectations with 9% YOY Sales Growth
Swiss pharmaceutical major Novartis AG (NYSE: NVS) has reported its financial results for the second...
CDE Drafts Proposal on Generic Drug Studies for Varieties without Reference Preparations
The Center for Drug Evaluation (CDE) has released a Notice on the “Generic Study for...
CDE Lists Three Home-Grown Drugs for Priority Review, Including Myopia Treatment
The Center for Drug Evaluation (CDE) website has indicated that three home-grown drugs are on...
China’s CDE Releases 69th Batch of Generic Chemical Reference Preparations for Public Review
The Center for Drug Evaluation (CDE) in China has released the 69th batch of chemical...
Shanghai Fosun Pharmaceutical Reported to Halt Sale of Stake in Gland Pharma
Indian media sources, including ET Now, have reported that Shanghai Fosun Pharmaceutical Group Co., Ltd...
ChengDu ShengNuo Biotech Secures NMPA Approval for Generic Firazyr Equivalent
ChengDu ShengNuo Biotech Co., Ltd (SHA: 688117), a China-based polypeptide specialist, has announced that it...
Hainan Poly Pharm Wins Health Canada Approval for Generic Cytovene-IV (Ganciclovir)
Hainan Poly Pharm Co., Ltd (SHE: 300630), a China-based pharmaceutical company, has announced that it...
Fujian Healthcare Security Bureau Updates Sunshine Procurement Mechanism for Drugs
The Fujian Provincial Healthcare Security Bureau has released the Notice on Adjusting and Improving the...
Hainan Poly Pharm’s Generic Gadovist Receives FDA Approval for MRI Use
China-based Hainan Poly Pharm Co., Ltd (SHE: 300630) has announced that it has received marketing...
NMPA Releases 65th Batch of Reference Drugs for Generic Quality Consistency Evaluation
The National Medical Products Administration (NMPA) has released the 65th batch of reference drugs for...
CDE Releases 67th Batch of Chemical Generic Reference Preparations
The Center for Drug Evaluation (CDE) has released the 67th batch of chemical generic reference...
Zhejiang Suspends Generic Nesina Trading Due to IP Disputes
Zhejiang’s Provincial Center for Drug & Medical Device Procurement has issued a notification suspending the...
Joincare’s Generic Seretide Accepted for NMPA Review
China-based Joincare Pharmaceutical Industry Group Co., Ltd (SHA: 600380) has announced that the market filing...
China’s NMPA Releases 64th Batch of Reference Drugs for Generic Quality Consistency Evaluation
China’s National Medical Products Administration (NMPA) has released the 64th batch of reference drugs for...
Jemincare’s Avatrombopag Market Filing Accepted for Review by China’s CDE
China-based Jiangxi Jemincare Group has announced that its market filing for avatrombopag maleate (20mg) has...
Ascletis Partners with Simcere for Ritonavir Supply in COVID-19 Drug Development
China-based Ascletis Pharma Inc. (HKG: 1672) has announced that its wholly-owned subsidiary Ascletis Pharmaceuticals Co.,...
Hengrui’s Generic Cyclophosphamide Capsules Approved by China’s NMPA
China-based Jiangsu Hengrui Pharmaceuticals (SHA: 600276) has announced receiving marketing approval from the National Medical...
Hainan Poly Pharm’s Generic Ganciclovir Approved in Denmark
China-based Hainan Poly Pharm Co., Ltd (SHE: 300630) has announced receiving marketing approval from the...
Zhongchao Partners with Natco Pharma to Distribute Drugs in China
Zhongchao Inc. (NASDAQ: ZCMD), a Shanghai-based online health education provider, has announced multiple agreements with...